Dietary Guidelines May Need Cultural Adaptation for African Americans
This study explored the acceptability of various dietary guidelines among African American adults and found significant improvements in diet quality with the Mediterranean diet.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study explored the acceptability of various dietary guidelines among African American adults and found significant improvements in diet quality with the Mediterranean diet.
This study examined the effects of a low-fat vegan diet versus a portion-controlled diet on weight loss and acid load in adults with type 1 diabetes, finding significant weight loss in the vegan group.
A randomized controlled trial found that a low-fat vegan diet significantly reduced insulin use and costs in adults with type 1 diabetes compared to a portion-controlled diet.
A 12-week randomized clinical trial found that adults with type 1 diabetes on a low-fat vegan diet showed greater improvements in insulin sensitivity compared to those on a portion-controlled diet.
A whole-food, plant-based lifestyle intervention significantly improved glycaemic control compared to standard medical care.
This study analyzed dietary fiber intake among users of a diabetes self-management app, finding an average intake of 17.1 g/day.
This study evaluated the efficacy and tolerability of a food supplement in individuals with impaired fasting blood glucose, finding significant improvements in fasting plasma glucose and lipid profiles.
This study evaluated the effects of resistance training with and without whey protein on glycemic parameters in elderly patients with type 2 diabetes and sarcopenic obesity, finding significant improvements in several outcomes with resistance training.
This study evaluated the use of glucocorticoids to manage cytokine release syndrome during teplizumab therapy for new-onset type 1 diabetes, finding a low incidence of cytokine release syndrome.
This study evaluated the effects of Canagliflozin on myocardial fibrosis in high-risk type 2 diabetes patients, finding significant reductions in extracellular volume and left ventricular metrics.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.